Literature DB >> 6705767

Vancomycin: renewed interest in an old drug.

B B Farber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6705767     DOI： 10.1007/bf02032805

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  14 in total

1.  Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant Staphylococcus aureus at a large community hospital.

Authors:  J J Klimek; F J Marsik; R C Bartlett; B Weir; P Shea; R Quintiliani
Journal:  Am J Med       Date:  1976-09       Impact factor: 4.965

2.  Prevention of staphylococcal shunt infections by continuous vancomycin prophylaxis.

Authors:  A J Morris; R T Bilinsky
Journal:  Am J Med Sci       Date:  1971-08       Impact factor: 2.378

3.  Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis.

Authors:  B E Magera; J C Arroyo; S J Rosansky; B Postic
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

4.  Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.

Authors:  F D Lowy; D S Chang; P R Lash
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

5.  Hazards of rapid administration of vancomycin.

Authors:  P Newfield; M F Roizen
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

6.  Treatment of infections due to methicillin-resistant Staphylococcus aureus.

Authors:  C Watanakunakorn
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

7.  Vancomycin prophylaxis in cardiac operations: determination of an optimal dosage regimen.

Authors:  B F Farber; A W Karchmer; M J Buckley; R C Moellering
Journal:  J Thorac Cardiovasc Surg       Date:  1983-06       Impact factor: 5.209

8.  Single-dose kinetics of intravenous vancomycin.

Authors:  D J Krogstad; R C Moellering; D J Greenblatt
Journal:  J Clin Pharmacol       Date:  1980-04       Impact factor: 3.126

9.  Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy.

Authors:  A W Karchmer; G L Archer; W E Dismukes
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

10.  Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

Authors:  R C Moellering; D J Krogstad; D J Greenblatt
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391
View more
  7 in total

1.  Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis.

Authors:  G L Traina; M G Gentile; G Fellin; R Rosina; L Cavenaghi; G Buniva; M Bonati
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  The study of vancomycin use and its adverse reactions associated to patients of a Brazilian university hospital.

Authors:  Daniel Savignon Marinho; Gisele Huf; Bruno L A Ferreira; Helena Castro; Carlos R Rodrigues; Valeria Pereira de Sousa; Lúcio M Cabral
Journal:  BMC Res Notes       Date:  2011-07-15

Review 3.  Structure, biochemistry and mechanism of action of glycopeptide antibiotics.

Authors:  P E Reynolds
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-11       Impact factor: 3.267

4.  Teicoplanin pharmacokinetics in patients with chronic renal failure.

Authors:  M Bonati; G L Traina; G Villa; A Salvadeo; M G Gentile; G Fellin; R Rosina; L Cavenaghi; G Buniva
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

5.  Activity of coumermycin against clinical isolates of staphylococci.

Authors:  M N Guillemin; H M Miles; M I McDonald
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

6.  Surveillance cultures and benefit of laminar airflow units in patients undergoing bone marrow transplantation.

Authors:  W Heizmann; G Ehninger; A Vallbracht; K Botzenhart
Journal:  Infection       Date:  1987       Impact factor: 3.553

7.  Long-term vancomycin use had low risk of ototoxicity.

Authors:  Clayton Humphrey; Michael P Veve; Brian Walker; Mahmoud A Shorman
Journal:  PLoS One       Date:  2019-11-06       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.